NCT06210750 2024-05-17Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)National Cancer Institute (NCI)Phase 2 Withdrawn